References

Acuff KL, Faden RR. A history of prenatal and newborn screening programs: lessons for the future. In: Faden RR, Feller F, and Powers M., eds. AIDS, Women, and the Next Generation: Towards a Morally Acceptable Public Policy for HIV Testing of Pregnant Women and Newborns . New York: Oxford University Press, 1991.

AIDS Policy Center for Children, Youth and Families. Fact sheet: Facts about access to HIV/AIDS drugs for children, youth, and families. April 1998.

AIDS Policy Center for Children, Youth and Families. Position statement on HIV testing. 1995.

Alderton D, CDC, HIV/AIDS Surveillance Branch, personal communication. April 8, 1998.

Allen, D, Gortmaker SL, Cotton DJ, Gardner JD. HIV counseling and testing by prenatal providers: impact of clinical policies on provider behavior. Unpublished.

American Academy of Pediatrics (AAP). Committee on Pediatric AIDS. Human milk, breast-feeding, and transmission of human immunodeficiency virus in the United States. Pediatrics 96:977-999, 1995a.

AAP. Provisional Committee on Pediatric AIDS. Perinatal human immunodeficiency virus test. Pediatrics 95:303-307, 1995b.

AAP and American College of Obstetricians and Gynecologists (ACOG). Guidelines for Perinatal Care. 4th Ed. Elk Grove Village, IL; Washington, DC: p. 75, 1997.

American Civil Liberties Union (ACLU). HIV Surveillance and Name Reporting: A Public Health Case for Protecting Civil Liberties. October 1997.

American College of Nurse Midwives. Division of Standards and Practices. Statement of HIV/AIDS. 1997.

American College of Obstetrics and Gynecology. Human immunodeficiency virus infections in pregnancy. ACOG Educational Bulletin 232, January 1997.

American Medical Association (AMA). Maternal HIV screening and treatment to reduce the risk of perinatal HIV transmission: An update report. Report 6 of the Council on Scientific Affairs (A-96). 1995.

AMA. Counseling and testing of pregnant women for HIV, Resolution 425. House of Delegates. 1996.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 134
--> References Acuff KL, Faden RR. A history of prenatal and newborn screening programs: lessons for the future. In: Faden RR, Feller F, and Powers M., eds. AIDS, Women, and the Next Generation: Towards a Morally Acceptable Public Policy for HIV Testing of Pregnant Women and Newborns . New York: Oxford University Press, 1991. AIDS Policy Center for Children, Youth and Families. Fact sheet: Facts about access to HIV/AIDS drugs for children, youth, and families. April 1998. AIDS Policy Center for Children, Youth and Families. Position statement on HIV testing. 1995. Alderton D, CDC, HIV/AIDS Surveillance Branch, personal communication. April 8, 1998. Allen, D, Gortmaker SL, Cotton DJ, Gardner JD. HIV counseling and testing by prenatal providers: impact of clinical policies on provider behavior. Unpublished. American Academy of Pediatrics (AAP). Committee on Pediatric AIDS. Human milk, breast-feeding, and transmission of human immunodeficiency virus in the United States. Pediatrics 96:977-999, 1995a. AAP. Provisional Committee on Pediatric AIDS. Perinatal human immunodeficiency virus test. Pediatrics 95:303-307, 1995b. AAP and American College of Obstetricians and Gynecologists (ACOG). Guidelines for Perinatal Care. 4th Ed. Elk Grove Village, IL; Washington, DC: p. 75, 1997. American Civil Liberties Union (ACLU). HIV Surveillance and Name Reporting: A Public Health Case for Protecting Civil Liberties. October 1997. American College of Nurse Midwives. Division of Standards and Practices. Statement of HIV/AIDS. 1997. American College of Obstetrics and Gynecology. Human immunodeficiency virus infections in pregnancy. ACOG Educational Bulletin 232, January 1997. American Medical Association (AMA). Maternal HIV screening and treatment to reduce the risk of perinatal HIV transmission: An update report. Report 6 of the Council on Scientific Affairs (A-96). 1995. AMA. Counseling and testing of pregnant women for HIV, Resolution 425. House of Delegates. 1996.

OCR for page 134
--> AMA. Counseling and testing of pregnant women for HIV [H-20.927]. HOD Policy. 1997. Association of Maternal and Child Health Programs (AMCHP). Policy on HIV Counseling and Testing. 1995. Association of Women's Health, Obstetric, and Neonatal Nurses (AWHONN). HIV Testing and Disclosure. 1995[www document] URL http://www.awhonn.org/resour/position/pshiv.html Baba TW, Koch J, Mittler ES, Greene M, Wyand M, Penninck D, Ruprecht R. Mucosal infection of neonatal rhesus monkeys with cell-free SIV. AIDS Res Hum Retrovirus 10:351-357, 1994. Barbacci MB, Repke JT, Chaisson RE. Routine prenatal screening for HIV infection. Lancet 337:709-711, 1991. Barton JJ, O'Connor TM, Cannon MJ, Weldon-Linne CM. Prevalence of human immunodeficiency virus in a general prenatal population. Am J Obstet Gynecol 160:1316-1324, 1989. Bayer R. Public health policy and the AIDS epidemic. An end to HIV exceptionalism? N Engl J Med 324(21):1500-1504, 1991. Bell LJ. Survey of prenatal care providers' screening practices. EPI Notes: Disease Prevention and Epidemiology Newsletter 19:1-2, 1997. South Carolina Department of Health and Environmental Control. Biggar, RJ, Miotti PG, Taha TE, Mtimavalye L, Broadhead R, Justesen A, Yellin F, Liomba G, Miley W, Waters D, Chiphangwi JD, Goedert JJ. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 347:1647-1650, 1996. Birkhead GS. New York AIDS Institute. Personal communication. 1998. Birkhead GS, Warren BL, Charbonneau TT. Evidence of intermediate rates of perinatal HIV-1 transmission with partial 076 regimens: Results of observational study. Abstract presented at Fifth Conference on Retroviruses and Opportunistic Infections. Chicago, IL. February 1-5, 1998. BlueSpruce J. Group Health Cooperative of Puget Sound. Personal communication, 1998. Blum RW, Beuhring T, Wunderlich M, Resnick MD. Don't ask, they won't tell: The quality of adolescent health screening in five practice settings. Am J Publ Health 86:1768, 1996. Borkowsky W, Krasinski K, Cao Y, Ho D, Pollack H, Moore T, Chen SH, Allen M, Tao PT. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J Pediatr 125:345-351, 1994. Bremer JW, Lew JF, Cooper E, Hillyer GV, Pitt J, Handelsman E, Brambilla D, Moye J, Hoff R. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr 129:198-207, 1996. Bulterys M, Chao A, Dushimimana A, Saah A. HIV-1 seroconversion after 20 months of age in a cohort of breast-fed children born to HIV-1 infected women in Rwanda. AIDS 9:93-94, 1995. Bureau of Justice Statistics. Correctional Populations in the United States, 1995. 1997. Byers Jr. RH, Caldwell MB, Davis S, Gwinn M, Lindegren ML. Projection of AIDS and HIV incidence among children born infected with HIV. Stat Med 17:169-181, 1998. Cao Y, Krogstad P, Korber BT, Koup RA, Muldoon M, Macken C, Song JL, Jin Z, Zhao JQ, Clapp S, Chen IS, Ho DD, Ammann AJ. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 3:549-552, 1997. Carusi D, Learman LA, Posner SF. Human immunodeficiency virus test refusal in pregnancy: A challenge to voluntary testing. Obstet Gynecol 91(4):540-545, 1998. Centers for Disease Control and Prevention (CDC). Public Health Service guidelines for antibody testing to prevent HIV infection and AIDS. MMWR 36:509-515, 1987. CDC Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 43(RR-11), 1994. CDC. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR 44(RR-4):1-10, 1995a.

OCR for page 134
--> CDC. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR 44(RR-7), 1995b. CDC. AIDS among children--United States. MMWR 45(46):1-4, 1996a. CDC. HIV/AIDS Surveillance Report 8(2), 1996b. CDC. AIDS Public Information Data Set: Data Through December 1996. 1997a. CDC. Fact sheet: Strategies for prevention of HIV in women. Atlanta: U.S. Department of Health and Human Services, 1997b. CDC. HIV/AIDS Surveillance Report 9(2), 1997c. CDC. HIV counseling and testing in publicly funded sites: 1995 summary report. Atlanta: U.S. Department of Health and Human Services, 1997d. CDC. Update: Perinatally acquired HIV/AIDS, United States, 1997. MMWR 46(46):1085-1092, 1997e. CDC. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 46(RR-12), 1997f. CDC. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998. MMWR 47(8):151-154, 1998a. CDC. Fact sheet: HIV prevention community planning: Successes and challenges. Atlanta: U.S. Department of Health and Human Services, 1998b. CDC. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR 47(RR-4), 1998c. CDC. Public Health Service Task Force's recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR 47(RR-2):1-25, 1998d. CDC. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR 47(RR-05), 1998e. CDC. Success in implementing PHS guidelines to reduce perinatal transmission of HIV--1993, 1995, and 1996. MMWR 47(33):688-691, 1998f. CDC. Update: HIV counseling and testing using rapid tests--United States, 1998. MMWR 47(11):211-215, 1998g. Chavkin W, Breitbart V, Elman D, Wise P. National survey of the states: Policies and practices regarding drug-using pregnant women. Am J Publ Health 88(1):117-119, 1998. Ching S, Paul S, Goldman K. The diffusion of HIV counseling among New Jersey obstetricians and gynecologists: Factors influencing levels of implementation. New Jersey Graduate Program in Public Health, Fieldwork Project, May 1997. Coates T, Stall R, Kegeles S, Lo B, Morin S, McKusick L. AIDS antibody testing: Will it stop the AIDS epidemic? Will it help people infected with HIV? Am Psychol 43:859-864, 1988. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ , VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy JF, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331(18):1173-1180, 1994. Cozen W, Mascola L, Enguidanos R. Screening for HIV and hepatitis B virus in Los Angeles county prenatal clinics: A demonstration project. J Acquir Immune Defic Syndr 6:95-98, 1993. Datta P, Embree JE, Kreiss JK, Ndinya-Achola JO, Braddick M, Temmerman M, Nagelkerke J, Maitha G, Holmes KK, Piot P, et al. Mother-to-child transmission of human immunodeficiency virus type 1: Report from the Nairobi study. J Infect Dis 170(5):1134-1140, 1994. Davis K. Uninsured in an era of managed care. Health Serv Res 31:641-649, 1997. Davis SF, Byers RH Jr., Lindegren ML, Caldwell MB, Karon JM, Gwinn M. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA 274(12):952-955, 1995. Department of Health and Human Services. Fact sheet: Medicaid and acquired immune deficiency syndrome (AIDS) and human immunodeficiency virus (HIV) infection. March 1998. [www document] URL http://hiv.hcfa.gov/medicaid/obs11.htm

OCR for page 134
--> DHHS. Volume 1. Natality. Vital Statistics of the United States. Hyattsville, MD: National Center for Health Statistics, 1992. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 275(8):559-605, 1996. D'Souza MP, Harden VA. Chemokines and HIV-1 second receptors. Nat Med 2:1293-1300, 1996. Doyle A, Jefferys R, Kelly J. State AIDS Drug Assistance Programs: A National Status Report on Access. Menlo Park, CA: Henry J. Kaiser Family Foundation, 1997. Duliege AM, Amos CI, Felton S, Biggar RJ, Goedert JJ. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International registry of HIV-exposed twins. J Pediatr 126(4):625-632, 1995. Dunn DT, Newell ML, Ades AE, Peckham C. Risk of human immunodeficiency virus type 1 transmission through breast-feeding. Lancet 340:585-588, 1992. Dupont-Merck. Communication to Investigators, Efavirenz Information. 1998. Ecker JL. The cost-effectiveness of human immunodeficiency virus screening in pregnancy. Am J Obstet Gynecol 174:716-721, 1996. Ehrnst A, Lindgren S, Dictor M, Johansson B, Sonnenborg A, Czajkowski J, Sundin G, Bohlin AB. HIV in pregnant women and their offspring: Evidence for late transmission. Lancet 338:203-207, 1991. Employee Benefits Research Institute (EBRI). Fact sheet: Characteristics of individuals with employment-based health insurance, 1987-1995. 1997. [www document] URL http://www.ebri.org/facts/0797fact.htm EBRI. Issues of quality and consumer rights in the health care market. EBRI Issue Brief 196, April 1998. Faden RR, Kass NE, Powers M. Warrants for screening programs: Public health, legal, and ethical frameworks. In: Faden RR, Feller G, Powers M, eds. AIDS, Women, and the Next Generation: Towards a Morally Acceptable Public Policy for HIV Testing of Pregnant Women and Newborns. New York: Oxford University Press, 1991. Faden R, Chwalow AJ, Holtzman NA, Horn SD. A survey to evaluate parental consent as public policy for neonatal screening. Am J Publ Health 72(12):1347-1352, 1982. Families USA Foundation. Field report: Balanced budget bill enacted. August 1997. Fiscus SA, Adimora AA, Schoenbach VJ, Lim W, McKinney R, Rupar D, Kenny J, Woods C, Wilfert C. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA 275(19):1483-1488, 1996. Fine A. National Welfare Reform: Impact on Maternal and Child Health. Washington, DC: Association of Maternal and Child Health Programs. 1997. Flanigan T. The Miriam Hospital, Brown University. Personal communication, 1998. Gamble V. A legacy of distrust: African Americans and medical research. Am J Prev Med 9:35-38, 1993. Gamble, V. Under the Shadow of Tuskegee: African Americans and Health Care. Am J Publ Health 87:1773-1778, 1997. Gorsky RD, Farnham PG, Straus WL, Caldwell B, Holtgrave DR, Simonds RJ, Rogers MF, Guinan ME. Preventing perinatal transmission of HIV: Costs and effectiveness of a recommended intervention. Public Health Rep 111(4):335-341, 1996. Gostin LO, Ward JW, Baker AC. National HIV case reporting for the United States. A defining moment in the history of the epidemic. N Engl J Med 337:1162-1167, 1997. Gostin LO, Webber D. The AIDS litigation project part II, HIV/AIDS in courts in the 1990s . AIDS and Public Policy Journal 13(2 Summer), 1998.

OCR for page 134
--> Gostin LO, Lazzarini Z, Ward J, Fleming P, Neslund V. State efforts to prevent perinatal HIV transmission: results of a national survey of state laws, regulations, policies, and guidelines. For Centers for Disease Control and Prevention. in Press. Hale RW, Zinberg S. American College of Obstetrics and Gynecologists' position on HIV testing. ACOG Clinical Review 2(1):13, 1997. Hamm RH, Donnell HD, Wilson E, Meredith K, Louise S. Prevention of perinatal HIV transmission: beliefs and practices of Missouri prenatal providers. Missouri Epidemiologist March-April:5-21, 1996. Havens PL, Cuene BE, Hand JR, Gern JE, Sullivan BW, Chusin MJ. Effectiveness of intensive nurse case management in decreasing vertical transmission of human immunodeficiency virus infection in Wisconsin. Pediatr Infect Dis J 16(9):871-875, 1997. Health Care Financing Administration (HCFA). Managed care trends. National Summary of Medicaid Managed Care Programs and Enrollment. June 30, 1997. [www document] URL http://www.hcfa.gov/medicaid/ome 1997.htm Health Resources and Services Administration (HRSA). Fact sheet: Title II Ryan White CARE Act . 1998a. [www. document] URL http://www.hrsa.dhhs.gov/hab/OC/factshee/titii.htm HRSA. Fact sheet. Title IV Ryan White CARE Act. 1998b. Healton C, Howard J, Messeri P, Sorin MD, Abramson D, Bayer R. A balancing act: The tension between case-finding and primary prevention strategies in New York State's voluntary HIV counseling and testing program in women's health care settings. Am J Prev Med 12(1 Suppl):53-60, 1996. Herczfeld, ND. A survey of prenatal care providers in Connecticut regarding their attitudes and practices pertaining to HIV/AIDS and pregnancy. Master of Public Health thesis, Yale University, Department of Epidemiology and Public Health, 1995. Hill B, Nevada State Health Division, HIV/AID Programs Office. Personal communication, 1998. Holtzman NA. Public participation in genetic policy making: The Maryland commission in hereditary disorders in genetics and the law. In: Malinsky A, Annas GJ, eds. Genetics and the Law. New York: Plenum, 1984. Husson RN, Lan Y, Kojima E, Venzon D, Mitsuya H, McIntosh K. Vertical transmission of human immunodeficiency virus type 1: Autologous neutralizing antibody, virus load, and virus phenotype. J Pediatr 126(6):865-871, 1995. Institute of Medicine (IOM). Reaching Mothers, Reaching Infants: Summary and Recommendations . Washington, DC: National Academy Press, 1988. IOM. Clinical Practice Guidelines: Direction for a New Program. Washington, DC: National Academy Press, 1990. IOM. HIV Screening of Pregnant Women and Newborns. Washington, DC: National Academy Press, 1991. IOM. Clinical Practice Guidelines: From Development to Use. Washington, DC: National Academy Press, 1992. IOM. AIDS and Behavior: An Integrated Approach. Washington, DC: National Academy Press, 1994. IOM. Assessing the Social and Behavioral Science Base for HIV/AIDS Prevention and Intervention. Washington, DC: National Academy Press, 1995a. IOM. The Best Intentions: Unintended Pregnancy and the Well-Being of Children and Families. Washington, DC: National Academy Press, 1995b. IOM. HIV and the Blood Supply: An Analysis of Crisis Decision making. Washington, DC: National Academy Press, 1995c. IOM. Measuring the Quality of Health Care--State of the Art. Washington, DC: National Academy Press, 1996a. IOM Opportunities in Drug Abuse Research Committee on Opportunities in Drug Abuse Research. Washington, DC: National Academy Press, 1996b.

OCR for page 134
--> IOM. The Hidden Epidemic. Washington, DC: National Academy Press, 1997. Intercollegiate Working Party for Enhancing Voluntary Confidential HIV Testing in Pregnancy. Royal College of Paediatrics and Child Health. Reducing Mother to Child Transmission of HIV Infection in the United Kingdom. London, England: April 1998. Irwin KL, Valdiserri RO, Holmberg SD. The acceptability of voluntary HIV antibody testing in the United States: A decade of lessons learned. AIDS 10:1707-1717, 1996. Jones J. Bad Blood: The Tuskegee Syphilis Experiment. 2nd. ed., New York: Free Press, 1993. Jos PH, Marshall MF, Perlmutter M. The Charleston policy on cocaine use during pregnancy: A cautionary tale. J Law Med Ethics 23:120-128, 1995. Kaiser Commission on the Future of Medicaid. Fact sheet: Medicaid and Managed Care. May, 1996. Kaiser Commission on Medicaid and Uninsured. Unpublished estimates based on Current Population Survey, using ages 18-44 for women and under 18 for children. March 1996. Kaiser Commission on Medicaid and Uninsured. Uninsured in America: A Chart Book. Menlo Park, CA: The Henry J. Kaiser Family Foundation, June 1998a. Kaiser Commission on Medicaid and Uninsured. Uninsured facts: The Uninsured and Their Access To Health Care. Menlo Park, CA: The Henry J. Kaiser Family Foundation, July 1998b. Kaiser Family Foundation. Abbot v. Bragdon: high court rules Americans with Disabilities Act protects patients with HIV. Daily HIV/AIDS Report. June 26, 1998a. [www document] URL http://report.kff.org/aidshiv/db2/1998/06/kh980626.1.html Kaiser Family Foundation. Understanding the Impact of New Treatments on HIV Testing: Summary of a forum held on January 28-30, 1998. 1998b. King P. Legal issues in voluntary screening for HIV infection in pregnant women. In: Faden RR, Feller F, Powers M., eds. AIDS, Women, and the Next Generation: Towards a Morally Acceptable Public Policy for HIV Testing of Pregnant Women and Newborns. New York: Oxford University Press, 1991. Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C, Garcia P, Fowler MG, Mofenson L, Tuomala R. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 334(25):1617-236, 1996. Lewis K, Ellwood M, Czajka JL. Counting the Uninsured: A Review of the Literature. Occasional Paper No. 8. Washington, DC: The Urban Institute. 1998 Limata C, Schoen EJ, Cohen D, Black SB, Quesenberry Jr CP. Compliance with voluntary prenatal HIV testing in a large health maintenance organization (HMO). J Acquir Immune Defic Syndr Hum Retrovirol 15(2):126-130, 1997. Lindegren ML. Prevalence of zidovudine use to reduce maternal-infant transmission, 1994-1995. Presentation at IOM Workshop on Perinatal Transmission of HIV, Washington, DC. April 1, 1998. Lindegren ML, Byers RH, Fleming P, Thomas P, Wortley P, Gwinn M, Ward J. Status of the perinatal HIV epidemic in the United States: Success in perinatal prevention [abstract 23306]. Presented at the Twelfth World AIDS Conference, Geneva, Switzerland. June 28-July 3, 1998. Lindsay MK. A protocol for routine voluntary antepartum human immunodeficiency virus antibody screening. Am J Obstet Gynecol 168(2):476-479, 1993. Lindsay MK, Adefris W, Peterson HB, Williams H, Johnson J, Klein L. Determinants of acceptance of routine voluntary human immunodeficiency virus testing in an inner-city prenatal population. Obstet Gynecol 78(4):678-680, 1991a. Lindsay MK, Feng TI, Peterson HB, Slade BA, Willis S, Klein L. Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients. Obstet Gynecol 77(4):599-603, 1991b. Lindsay MK., Peterson HB, Willis S, Slade BA, Gramling J, Williams H, Klein L. Incidence and prevalence of human immunodeficiency virus infection in a prenatal population undergoing routine voluntary human immunodeficiency virus screening, July 1987 to June 1990. Am J Obstet Gynecol 165(4, Pt 1):962-964, 1991c.

OCR for page 134
--> Lorenzi P, Masserei V, Laubereau B, Irion O, Kind C, Rudin C, Hirschel B, Kaiser L. Safety of combined anitretroviral therapies with or without protease inhibitors in pregnant HIV-infected women and their offspring [abstract No. 32453] Presented at the Twelfth World AIDS Conference. Geneva, Switzerland. June 28-July 3, 1998. Lovvorn A, Quinn S. HIV testing of pregnant women: A policy analysis. J Publ Health Policy 18:401-432, 1997. Louisiana Morbidity Report. Prevention of Perinatal HIV Transmission. 6(5):November-December, 1995. Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 337:853-856, 1997. Luzuriaga K, Bryson Y, Krogstad P, Robinson J, Stechenberg B, Lamson M, Cort S, Sullivan JL. Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection. N Engl J Med 336(19):1343-1349, 1997. Luzuriaga K, McQuilken P, Alimenti A, Somasundaran M, Hesselton R, Sullivan JL. Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection. J Inf Dis 167:1008-1013, 1993. Luzuriaga K, Sullivan JL. DNA polymerase chain reaction for the diagnosis of vertical HIV infection. JAMA 275(17):1360-1361, 1996. Mandelbrot L, Le Cheandec J, Berrebi A, Bongain A, Benifla JL, Delfraissy JF, Blanche S, Mayaux MJ. Perinatal HIV-1 transmission: Interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 280:55-60, 1998. Mandelbrot L, Mayaux MJ, Bongain A, Berrebi A, Moudoub-Jeanpetit Y, Benifla JL, Ciraru-Vigneron N, Le Chenadec J, Blanche S, Delfraissy JF. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 175(3 Pt 1):661-667, 1996. Mason J, Preisinger J, Sperling R, Walther V, Berrier J, Evans V. Incorporating HIV education and counseling into routine prenatal care: A program model. AIDS Educ Prev 3(2):118-123, 1991. Mauskopf JA, Paul JE, Wichman DS, White AD, Tilson HH. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening. JAMA 276(2):132-138, 1996. Mayaux MJ, Teglas JP, Mandelbrot L, Berrebi A, Gallais H, Matheron S, Viraru-Vigneron N, Parnet-Mathieu F, Bongain A, Rouzioux C, Delfraissy JF, Blanche S. Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France. J Pediatr 131:857-862, 1997. Michigan Department of Community Health. Improving the odds: Reducing perinatal HIV transmission: Report of the recommendations of the Maternal Child Health Advisory Committee, Subcommittee on Perinatal HIV Reduction. 1997. Michigan Department of Community Health. Trends in perinatal HIV Transmission in Michigan. 1998. Mills WA, Martin DL, Bertrand, Belongia EA. Physicians' practices and opinions regarding prenatal screening for human immunodeficiency virus and other sexually transmitted diseases. Sex Trans Dis 25(3):169-175, 1998. Minkoff H, Burns SN, Landesman S, Youchah J, Goedert JJ, Nugent RP, Muenz LR, Willoughby AD. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 173(2):585-589, 1995. Minkoff H, O'Sullivan MJ. The case for rapid HIV testing during labor. JAMA 279:1743-1744, 1998. Mitchell B. Preliminary analyses of 1997 Texas birth certificate data, personal communication. Texas Department of Health, 1998.

OCR for page 134
--> Mofenson L. Session 11, Advances in HIV prevention: Prevention of perinatal HIV transmission. Presented at the Fifth Conference on Retroviruses and Opportunistic Infection. Chicago, IL. February 1-5, 1998. Montana Department of Public Health and Human Services, Communicable Disease Control and Prevention Bureau, STD/HIV Section: DPHHS HIV Screening Survey Results. 1996 Myers ER, Thompson JW, Simpson K. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy. Obstet Gynecol 91(2):164-181, 1998. National Academy of Sciences (NAS). Genetic Screening: Programs, Principles, and Research. Washington, DC: National Academy Press, 1975. National Center for Health Statistics (NCHS). Health. United States, 1996-1997 and Injury Chart book. Hyattsville, MD. 1997. National Institutes of Health (NIH). Consensus statement. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA 258(9):1205-1209, 1987. NIH. Interventions to prevent HIV risk behaviors. NIH Consensus Statement 15(2):1-41, 1997. National Research Council (NRC). AIDS: Sexual Behavior and Intravenous Drug Use. Washington, DC: National Academy Press, 1989. NRC. AIDS: The Second Decade. Washington, DC: National Academy Press, 1990. NRC. Evaluating AIDS Prevention Programs (Expanded Edition). Washington, DC: National Academy Press, 1991. NRC. The Social Impact of AIDS in the United States. Washington, DC: National Academy Press, 1993. NRC. Prevention HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press, 1995. New York Department of Health, Maternal-Perinatal HIV Prevention and Care Program. Newborn HIV testing program update: Infants born February 1 to October 31, 1997. 1997. New York Post. 13,000 Babies. January 5, 1938 p.1. Newton ZB, Bell WC. HIV perinatal prevention project: Contact and survey of metro Atlanta obstetricians. Georgia Obstetrical and Gynecological Society, July 21, 1997. Nyquist C. HIV testing of pregnant women in Colorado. Undated abstract. Ohio Department of Health. Perinatal HIV counseling and testing survey. October 31, 1997. Palasanthiran P, Ziegler JB, Stewart GJ, Stuckey M, Armstrong JA, Cooper DA, Penny R, Gold J. Breast-feeding during primary human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis 167:441-444, 1993. Partika N. John A Burns School of Medicine, Department of Psychiatry, Kapiolani Medical Center for Women and Children, University of Hawaii at Manoa. Personal communication. 1998. Partika N, Johnson J. Results of a survey of Hawaii ob/gyns and family practice physicians regarding perinatal transmission of HIV: During time period from July 1, 1996 to June 30, 1997. 1997. Paul SM, Dimasi LG, Costa SJ, Beil J, Cross A, Morgan DH. Evaluation of ZDV administration to pregnant women and their children born in 1993 through 1996 in New Jersey [poster #23287] Presented at the Twelfth World AIDS Conference. Geneva, Switzerland. June 28-July 3, 1998a. Paul SM, Cross H, Costa SJ, Pemberton G, Ching S, Dimasi L, Beil J , Palmer D, Pierce M, Caswell B, Morgan DH, Ziskin LZ. A comprehensive evaluation of implementation of the Public Health Service recommendations to prevent perinatal HIV transmission. Presentation at IOM Workshop. April 1, 1998b. Pemberton G. Knowledge, attitude, beliefs and intentions surrounding AZT use: A study of pregnant women's perception. Master's thesis, New Jersey Graduate Program in Public Health, September 3, 1997. Perez-Pena, R. Bill to track people infected with HIV gains in Albany. New York Times. June 19, 1998, P.A30.

OCR for page 134
--> Pettiti DB, Department of Research and Evaluation, Southern California Permanente Medical Group; Percentage of pregnant members of Southern California Kaiser Permanente tested for HIV by area, 1994-1997, Personal communication, April 30, 1998. Phillips KA, Morrison KR, Sonnad SS, Bleecker T. HIV counseling and testing of pregnant women and women of childbearing age by primary care providers: Self-reported beliefs and practices. Acquir Immune Defic Syndr Hum Retrovirol 14:174-178, 1997. Pilon. Alberta adds HIV test to prenatal screening. Edmonton Sun. August 6, 1998. Pliner V, Weedon J, Thomas PA, Steketee RW, Abrams EJ, Lambert G, Greenberg B, Banji M, Thea DM, Matheson PB. Incubation period of HIV-1 in perinatally infected children, New York City perinatal HIV transmission collaborative study group. AIDS 12:759-766, 1998. Popek EJ, Korber BT, Merritt L, Bardenguez A, Lee A, Hammill HA, Wiznia A, Viscarello R, Luzuriaga K, Van Dyke RB. Acute chorioamnionitis and duration of membrane rupture correlates with vertical transmission of HIV-1. Poster presented at the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 22-26, 1997. Quinn S. Belief in AIDS as a form of genocide: Implications for HIV prevention programs for African Americans. Journal of Health Education 28:S6-S11, 1998. RAND. Unpublished data from HIV Cost and Services Utilization Study. 1998. Report of a Consensus Workshop. Maternal factors involved in mother-to-child transmission of HIV-1. J AIDS 5:1019-1029, 1992. Rhame F, Maki D. The case for wider use of testing for HIV infection. N Engl J Med 320:1248-1254, 1989. Riley CW. Perinatal HIV infection white paper. Virginia Department of Health, Division of STD/AIDS, January 1998. Rodriguez EM, Mofenson LM, Chang BH. Association of maternal drug use during pregnancy with maternal culture positivity and perinatal human immunodeficiency virus transmission. AIDS 10:273-282, 1996. Rogers MF. Epidemiology of HIV/AIDS in women and children in the USA. Acta Paediatr 421:15-16, 1997. Rogers, MF, Caldwell MB, Gwinn ML, Simonds RJ. Epidemiology of pediatric human immunodeficiency virus infection in the United States. Acta Paediatr Suppl 400:5-7, 1994. Rogers MF, Ou CY, Rayfield M, Thomas PA, Schoenbaum EE, Abrams E, Krasinski K, Selwyn PA, Moore J, Kaul A, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med 320(25): 1649-1654, 1989. Rosenberg KD, Townes JM, Gonzales K, Modesitt SK, Fleming DW. HIV screening practices of Oregon prenatal care providers. Center for Disease Prevention and Epidemiology, Oregon Health Division. Undated abstract. Rosenberg PS, Biggar RJ, Goedert JJ. Declining age at HIV infection in the United States. New Engl J Med 167:1096-1099, 1994. Royce RA., Walter EB, Eckman A, Bennett B. Public health efforts to prevent vertical HIV transmission in North Carolina. Presentation at IOM Workshop on Perinatal Transmission of HIV, Washington, DC, April 1, 1998. Rubin T. Health Care Finances Administration (HCFA): Impact of the PHS voluntary testing recommendations: Results from providers and patient survey and state data systems. Presentation at the IOM Workshop on Perinatal Transmission of HIV, Washington, DC, April 1, 1998. Ruff AJ, Coberly J, Halsey NA, Boulos R, Desormeaux J, Burnley A, Joseph DH, McBrien M, Quinn T, Losikoff P, et al. Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors. J Acquir Immune Defic Syndr 7:68-73, 1994. Sage AC, Mahon B, Colfort Jr. JM. HIV counseling and testing practices of prenatal care providers in California. Unpublished.

OCR for page 134
--> Scarlatti, G, Hodara V, Rossi P, Muggiasca L, Bucceri A, Albert J, Fenyo EM. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. Virology 197(2):624-629, 1993. Schoen EJ. Northern California Kaiser Permanente Health Plan. Personal communication, 1998. Scott R. Sickle-cell anemia, high prevalence and low priority. N Engl J Med 282:164-165, 1970. Segal AI. Physician attitudes toward human immunodeficiency virus testing in pregnancy. Am J Obstet Gynecol 174(6):1750-1756, 1996. Semba RD, Miotti P, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 343:1593-1597, 1994. Shakarishvili A, Schulte J, Levine W, Kreitner S, Caldwell B, St. Louis M. Lack of timely prenatal care among women infected with HIV: Implications for prevention of perinatal HIV transmission in the United States. Abstract presented at the Eleventh International Conference on AIDS, Vancouver, BC, July 7-12, 1996. [www document] URL http://sis.nlm.nih.gov/aidsabs.htm Siegel K, Gorey E. HIV-infected women: Barriers to AZT use. Soc Sci Med 45(1):15-22, 1997. Silverman NS, Rohner DM, Turner BJ. Attitudes toward health-care, HIV infection, and perinatal transmission interventions in a cohort of inner-city, pregnant women. Am J Prenatal 14(6):341-346, 1997. Simonds RJ, Rogers M. Impact of the PHS voluntary testing recommendations. Results from CDC's surveillance and enhanced surveillance systems. Presentation at IOM Workshop on Perinatal Transmission of HIV, Washington DC, April 1, 1998. Simpson JL, Nadler HL. Maternal serum alpha-fetoprotein screening in 1987. Obstet Gynecol 69:134-134, 1987. Simpson W, Hart G, Johnston FD, Goldberg DJ, Boyd FM. Comparison of opt-in and opt-out HIV testing in antenatal care: uptake and acceptability in Edinburgh, Scotland [abstract #43120]. Abstract presented at the Twelfth World AIDS Conference, Geneva, Switzerland. June 28-July 3, 1998. Sperling RS, Shapiro DE, Coombs RW, Todd LA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study group. N Engl J Med 335(22):1621-1629, 1996. Sprecher S, Soumenkoff G, Puissant F, Degueldre MD. Vertical transmission of HIV in 15 week fetus. Lancet 2:288-289, 1986. Stoddard T, Reiman W. AIDS and the rights of the individual: Toward a more sophisticated understanding of discrimination. Milbank Q 68 (Suppl 1):143-174, 1990. Study EC. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 94:815-819, 1994. Thea DM, Steketee RW, Pliner V, Bornschlegel K, Brown T, Orloff S, Matheson PB, Abrams EJ, Bamji M, Lambert G, Schoenbaum EA, Thomas PA, Heagarty M, Kalish ML. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS 11(4):437-444, 1997. Thomas S, Quinn S. Presidential apology for the Study at Tuskegee (1997). 1998 Medical and Health Annual. Chicago, IL: Encyclopedia Britannica, 280-281, 1997. Turner BJ, Markson L, Hauck W, Cocroft J, Fanning T. Prenatal care of HIV-infected women: Analysis of a large New York State cohort. J Acquir Immune Defic Syndr Hum Retrovirol 9(4):371-378, 1995. Turner BJ, McKee-Nelsen L, Fanning TR, Hauck WW. Prevention of vertical HIV transmission with zidovudine: Projected impact of HIV testing and prenatal care. AIDS Care 9(5):577-588, 1997. U.S. Public Health Service (USPHS). Syphilis in Mother and Child. Supplement 7 to Venereal Disease Information (Washington, DC: Government Printing Office, 1940), 1. Urban Institute. Counting the Uninsured: A Review of the Literature. Occasional Paper No. 8. 1998.

OCR for page 134
--> Ventura SJ, Peters KD, Martin JA, Maurer JD. Births and deaths: United States, 1996. Monthly Vital Statistics Report 46(1S2):12. Hyattsville, MD: National Center for Health Statistics. 1997. Ventura SJ, Martin JA, Curtin SC, Mathews TJ. Report of final natality statistics, 1996. Monthly Vital Statistics 4(11):43. Hyattsville, MD: National Center for Health Statistics. 1998. Walter EB, Elliott AJ, Regan AN, Drucker RP, Clements DA, Wilfert CM. Maternal acceptance of voluntary human immunodeficiency virus antibody testing during the newborn period with the Guthrie card. Pediatr Infect Dis J 14:376-381, 1995. Walter EB, Lampe MA, Livingston E, Royce RA. How do North Carolina prenatal care providers counsel and test pregnant women for HIV? Survey measures knowledge of HIV testing benefits. NC Med J 59:105-109, 1998. Webber MP, Schoenbaum EE, Bonuck KA. Correlates of voluntary human immunodeficiency virus antibody testing reported by postpartum women. JAMWA 52(2):89-92, 1997. Wehr E, Fagan M, Blake S, Rosenbaum S. HIV/AIDS Related Provisions of Medicaid Managed Care Contracts. Menlo Park, CA: Henry J. Kaiser Family Foundation. 1998. Weil A. The new children's health insurance program. Should states expand Medicaid? New Federalism: Issues and Options for the States. Series A (A13), Washington, DC: Urban Institute. 1997 Weiser B, Nachman S, Tropper P, Viscosi KH, Grimson R, Baxter G, Fang G, Reyelt C, Hutcheon N, Burger H. Quantitation of human immunodeficiency virus type 1 during pregnancy: Relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA 91(17):8037-8041, 1994. Weisman C. Women's use of health care. In Falik MM, Collins KS, eds. Women's Health: The Commonwealth Survey. 25-32. Johns Hopkins University Press, 1996. Wilson JMG, Jungner F. Principles and practice of screening for disease. Public Health Paper 34. Geneva: WHO, 1968. Wisconsin AIDS/HIV Program. HIV antibody testing among pregnant women in Wisconsin, 1996. April 1997. Wiznia AA, Crane M, Lambert G, Sansary J, Harris A, Solomon L. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center. JAMA 275(19):1504-1506, 1996. World Health Organization (WHO). HIV and infant feeding. July 17, 1998. [www document] URL http://www.unaids.org/unaids/document/epidemio/infant.html Wortley PM, Fleming PL. AIDS in women in the United States. JAMA 278(11):911-916, 1997. Ziegler JB, Johnson RO, Cooper DA, Gold J. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1:896-898, 1985.